Evrópusambandið - enska - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ritonavir - hiv infections - antivirals for systemic use, - ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv-1-infected patients (adults and children of two years of age and older).,

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - oral solution - 20mg/1ml ; 80mg/1ml

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - tablet - 50mg ; 200mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - tablet - 25mg ; 100mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir - tablet - 100mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir - powder - 100mg

Malta - enska - Medicines Authority

accord healthcare limited - ritonavir - film-coated tablet - ritonavir 100 mg - antivirals for systemic use

Malta - enska - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - ritonavir - film-coated tablet - ritonavir 100 mg - antivirals for systemic use

Evrópusambandið - enska - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - nirmatrelvir; ritonavir -